SCHEMBL9229878

SCHEMBL9229878

Cc1ccc(O)c2c(C)cc(O)cc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 3/20 0.46
▸ ESR2 Q92731 3/20 0.46
▸ CLK2 P49760 1/20 0.42
▸ CYP3A4 P08684 5/20 0.39
▸ ALOX15 P16050 2/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ MAOA P21397 1/20 0.39
▸ TBXA2R P21731 1/20 0.39
▸ ADRA1A P35348 1/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ KMT2A Q03164 2/20 0.38
▸ OPRK1 P41145 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ PIM1 P11309 2/20 0.38
▸ NUAK1 O60285 1/20 0.38
▸ IGF1R P08069 1/20 0.38
▸ SRC P12931 1/20 0.38
▸ KDR P35968 1/20 0.38
▸ PLK1 P53350 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13021190 0.71 ACHE (0.44) ESR1ESR2CYP3A4ALOX15CHRM1
SCHEMBL27728436 0.71 CYP1A2 (0.52) ESR2CYP3A4ALOX15KMT2AOPRK1
SCHEMBL8923992 0.71 OPRK1 (0.44) ESR1ESR2CYP3A4ALOX15KMT2A
SCHEMBL9621794 0.71 OPRK1 (0.44) ESR1ESR2CYP3A4ALOX15KMT2A
SCHEMBL29771848 0.71 OPRK1 (0.44) ESR1ESR2CYP3A4ALOX15KMT2A
SCHEMBL20613620 0.71 OPRK1 (0.36) ESR1ESR2CYP3A4ALOX15KMT2A
SCHEMBL15586477 0.70 PIM1 (0.50) ESR1ESR2CYP3A4ALOX15KMT2A
SCHEMBL8773048 0.70 CYP3A4 (0.55) ESR1ESR2CLK2CYP3A4ALOX15
SCHEMBL7046582 0.68 MAPT (0.52) ESR2CYP3A4ALOX15TDP1SLC6A2
SCHEMBL21971077 0.68 CYP3A4 (0.42) ESR1ESR2CLK2CYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3265447-B1 BENZOXAZINE LOW TEMPERATURE CURABLE COMPOSITION HUNTSMAN ADVANCED MAT AMERICAS LLC (US) 2023-03-01 — — EP disclosed
CN-107428708-B Benzoxazine low temperature curable compositions 亨斯迈先进材料美国有限责任公司 2021-11-09 — — CN disclosed
US-20180030264-A1 Benzoxazine Low Temperature Curable Composition HUNTSMAN ADVANCED MATERIALS AMERICAS LLC 2018-02-01 — — US disclosed
EP-0661322-A2 Modified polyepoxy compound, process for producing the compound, and epoxy resin composition SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1995-07-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180030264-A1 Benzoxazine Low Temperature Curable Composition CRYZ, PIEZO1, PSMD12 ESR1 171/4885ESR2 858/4885CLK2 2662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback